Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is LSALT Peptide. The Company is engaged in the clinical development of LSALT Peptide and other DPEP-1 targeting drug candidates for indications where inflammation of the lungs, liver and kidneys is an unmet problem. LSALT Peptide is in a second phase II trial, targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). The Company has additional technology platforms in its portfolio, which are AB569 and Borg. AB569 is an anti-infective candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds.


TSXV:ARCH - Post by User

Post by Riverfolkon Oct 12, 2021 4:22pm
155 Views
Post# 33998685

2.22 All Time High w/ Close House Positions

2.22 All Time High w/ Close House Positions
House Positions for C:ARCH from 20211012 to 20211012
House Bought $Val Ave Sold $Val Ave Net $Net
22 Fidelity 42,800 92,354 2.158 3,500 7,525 2.15 39,300 -84,829
7 TD Sec 35,036 75,664 2.16 4,654 10,082 2.166 30,382 -65,582
79 CIBC 13,050 28,057 2.15 2,915 6,224 2.135 10,135 -21,833
13 Instinet 10,900 23,437 2.15 4,600 9,841 2.139 6,300 -13,596
80 National Bank 5,742 12,229 2.13 1,050 2,307 2.197 4,692 -9,922
85 Scotia 3,741 8,084 2.161 500 1,090 2.18 3,241 -6,994
2 RBC 4,900 10,593 2.162 1,888 4,119 2.182 3,012 -6,474
124 Questrade 200 438 2.19 0   200 -438
53 Morgan Stanley 4 8 2.00 0   4 -8
68 Leede 200 428 2.14 218 467 2.142 -18 39
84 Ind Trading 0   100 219 2.19 -100 219
19 Desjardins 0   278 606 2.18 -278 606
14 ITG 0   370 809 2.186 -370 809
143 Pershing 0   4,400 9,680 2.20 -4,400 9,680
89 Raymond James 13,000 28,226 2.171 20,100 43,366 2.158 -7,100 15,140
9 BMO Nesbitt 0   30,500 64,636 2.119 -30,500 64,636
1 Anonymous 37,800 80,832 2.138 92,300 199,379 2.16 -54,500 118,547
TOTAL 167,373 360,350 2.153 167,373 360,350 2.153 0 0

<< Previous
Bullboard Posts
Next >>